Metis Global Partners’s American Healthcare REIT AHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.62M Buy
50,167
+3,690
+8% +$181K 0.06% 248
2026
Q1
$2.19M Buy
46,477
+4,633
+11% +$230K 0.05% 276
2025
Q4
$1.97M Buy
41,844
+5,888
+16% +$273K 0.05% 323
2025
Q3
$1.51M Buy
35,956
+9,565
+36% +$384K 0.04% 379
2025
Q2
$970K Buy
26,391
+7,000
+36% +$233K 0.03% 471
2025
Q1
$588K Buy
19,391
+2,299
+13% +$66.3K 0.02% 563
2024
Q4
$486K Buy
17,092
+3,535
+26% +$95.1K 0.01% 594
2024
Q3
$354K Buy
+13,557
New +$264K 0.01% 642

Other funds holding AHR

Metis Global Partners's AHR Position: Q2 2026 in Review

Metis Global Partners increased its American Healthcare REIT (AHR) stake by 7.9% in Q2 2026, buying an estimated $181K and bringing the position to 50,167 shares worth $2.62M. The position accounts for 0.06% of the portfolio, ranked #248.

Metis Global Partners first reported a position in AHR in Q3 2024 and has held it in 8 quarters since. 568 funds tracked by Wall St. Rank hold AHR as of Q2 2026.

  • Metis Global Partners held 50,167 shares of American Healthcare REIT worth $2.62M as of Q2 2026.
  • Metis Global Partners bought 3,690 American Healthcare REIT shares in Q2 2026, an estimated $181K.
  • American Healthcare REIT made up 0.06% of Metis Global Partners's portfolio in Q2 2026, its #248 holding.
  • Metis Global Partners first reported a position in American Healthcare REIT in Q3 2024 and has held it in 8 quarters since.
  • 568 funds tracked by Wall St. Rank held American Healthcare REIT as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.